In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates

American Journal of Psychiatry

Volumn 155, Issue 8, 1998, Pages 1023-1028

  Heinz, Andreas ^a   Higley, J Dee ^b   Gorey, Julia G ^b   Saunders, Richard C ^b   Jones, Douglas W ^b   Hommer, Daniel ^b   Zajicek, Kristin ^b   Suomi, Stephen J ^b   Lesch, Klaus Peter ^b   Weinberger, Daniel R ^b   Linnoila, Markku ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; RADIOLIGAND; SEROTONIN TRANSPORTER;

AGGRESSION; ALCOHOL INTOXICATION; ANIMAL EXPERIMENT; ARTICLE; MACACA; MALE; NONHUMAN; PRIORITY JOURNAL; SEPARATION ANXIETY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031848037     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.155.8.1023     Document Type: Article

References (41)

1. Murphy JM, McBride WJ, Lumeng L, Li TK: Contents of monoamines in forebrain regions of alcohol-preferring (P) and non-preferring (NP) lines of rats. Pharmacol Biochem Behav 1987; 26:389-392
2. McBride WJ, Murphy JM, Lumeng L, Li TK: Serotonin, dopamine and GABA involvement in alcohol drinking in selectively bred rats. Alcohol 1989; 7:199-205
3. Wong DT, Threlkeld PG, Lumeng L, Li TK: Higher density of serotonin-1A receptors in the hippocampus and cerebral cortex of alcohol-preferring P rats. Life Sci 1990; 46:231-235
4. Zhou FC, Bledsoe S, Lumeng L, Li TK: Serotonergic immunostained terminal fibers are decreased in selected brain areas of alcohol-preferring rats (abstract). Alcohol Clin Exp Res 1990; 14:355A
5. Linnoila M, Virkunnen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK: Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 1983; 33:2609-2614
6. Kruesi MJ, Rapoport JL, Hamburger S, Hibbs E, Potter WZ, Lenane M, Brown GL: Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Arch Gen Psychiatry 1990; 47:419-426
7. Virkunnen M, Kallio E, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff C, Bissette G, Kalogeras K, Karonen SL, Linnoila M: Personality profiles and state aggressiveness in Finnish alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 1994; 51:28-33
8. Higley JD, Mehlman PT, Taub DM, Higley SB, Suomi SJ, Vickers JD, Linnoila M: Cerebrospinal fluid monoamine and adrenal correlates of aggression in free-ranging rhesus monkeys. Arch Gen Psychiatry 1992; 49:436-441
9. Higley JD, Suomi SJ, Linnoila M: A nonhuman primate model of type II excessive alcohol consumption? part 1: low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations and diminished social competence correlate with excessive alcohol consumption. Alcohol Clin Exp Res 1996; 20:629-642
10. Higley JD, Suomi SJ, Linnoila M: A nonhuman primate model of type II alcoholism? part 2: diminished social competence and excessive aggression correlates with low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations. Alcohol Clin Exp Res 1996; 20:643-650
11. Schuckit MA, Klein J, Twitchell G, Smith T: Personality test scores as predictors of alcoholism almost a decade later. Am J Psychiatry 1994; 151:1038-1042
12. Schuckit M, Smith TL: An 8-year follow-up of 450 sons of alcoholic and control subjects. Arch Gen Psychiatry 1996; 53:202-210
13. Fils-Aime ML, Eckhardt MJ, George DT, Brown GL, Mefford I, Linnoila M: Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics. Arch Gen Psychiatry 1996; 53:211-216
14. Cloninger CR: A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Developments 1986; 4:167-226
15. Cloninger CR: Neurogenetic adaptive mechanisms in alcoholism. Science 1987; 236:410-416
16. Irwin M, Schuckit M, Smith TL: Clinical importance of age at onset in type 1 and type 2 primary alcoholics. Arch Gen Psychiatry 1990; 47:320-324
17. Cloninger CR, Bohman M, Sigvardsson S: Inheritance of alcohol abuse. Arch Gen Psychiatry 1981; 38:861-868
18. Higley JD, Suomi SJ, Linnoila M: CSF monoamine metabolite concentrations vary according to age, rearing, and sex, and are influenced by the stressor of social separation in rhesus monkeys. Psychopharmacology (Berl) 1991; 103:551-556
19. Clarke AS, Hedecker DR, Ebert MH, Schmidt DE, McKinney WT, Kraemer GW: Rearing experience and biogenic amine activity in infant rhesus monkeys. Biol Psychiatry 1996; 40:338-352
20. Goldman D: Why mice drink. Nature Genetics 1996; 13:137-138
21. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Mller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274:1527-1531
22. Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, al-Tikriti MS, Sybirska EH, Zimmermann RC, Wiesniewski G, Neumeyer JL, Milius RA, Wang S, Smith EO, Roth RH, Charney DS, Hoffer PB, Innis RB: SPECT imaging of dopamine and serotonin transporters with [123I]β-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 1993; 13:295-309
23. Pirker W, Asenbaum S, Kasper S, Walter H, Angelberger P, Koch G, Pozzera A, Deecke L, Podreka I, Bruecke T: β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. J Neural Transm 1995; 100: 247-256
24. Doudet D, Hommer D, Higley JD, Andreason PJ, Moneman R, Suomi SJ, Linnoila M: Cerebral glucose metabolism, CSF 5-HIAA levels, and aggressive behavior in rhesus monkeys. Am J Psychiatry 1995; 152:1782-1787
25. Bacopoulos NG, Redmond DE, Roth RH: Serotonin and dopamine metabolites in brain regions and cerebrospinal fluid of primate species: effects of ketamine and fluphenazine. J Neurochem 1979; 32:1215-1218
26. Brammer GL, Raleigh MJ, McGuire MT, Rubinstein EH: Comparison of ketamine, physical restraint, halothane and pentobarbital: lack of influence on serotonergic measures in monkeys and rats. Neuropharmacology 26:1615-1621
27. Higley JD, Suomi SJ, Linnoila M: A longitudinal assessment of CSF monoamine metabolite and plasma cortisol concentrations in young rhesus monkeys. Biol Psychiatry 1992; 32:127-145
28. Baldwin RM, Zea-Ponce Y, Zoghbi SS, Laruelle M, al-Tikriti MS, Sybirska EH, Malison RT, Neumeyer JL, Milius RA, Wang S, Stabin M, Smith EO, Charney DS, Hoffer PB, Innis RB: Evaluation of the monoamine uptake site ligand [123I]methyl 3 β-(4-iodophenyl)-tropane-2 β-carboxylate ([123I]-βCIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI. Nuclear Medicine and Biology 1993; 20:597-606
29. Jagust WJ, Eberling JL, Biegon A, Taylor SE, VanBrocklin HF, Jordan S, Hanrahan SM, Roberts JA, Brennan KM, Mathis CA: Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter. J Nucl Med 1996; 37:1207-1214
30. Laruelle M, Wallace E, Seibyl JP, Baldwin RM, Zea-Ponce Y, Zoghbi SS, Neumeyer JL, Charney DS, Hoffer PB, Innis RB: Graphical, kinetic, and equilibrium analyses of in vivo [123-I]β-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 1994; 14:982-994
31. Fisher RE, Morris ED, Alpert NM, Fischman AJ: In vivo imaging of neuromodulatory synaptic transmission using PET: a review of relevant neurophysiology. Human Brain Mapping 1995; 3: 24-34
32. Morris ED, Fisher RE, Alpert NM, Rauch SL, Fischman AJ: In vivo imaging of neuromoduation using positron emission tomography: Optimal ligand characteristics and task length for detection of activation. Hum Brain Mapping 1995; 3:35-55
33. Mash DC, Staley JK, Doepel FM, Young SN, Palmour RM: Altered dopamine transporter densities in alcohol-preferring vervet monkeys. Neuroreport 1996; 7:457-462
34. Baumgarten HG, Grozdanovic Z: Psychopharmacology of central serotonergic systems. Pharmacopsychiatry 1995; 28(suppl 2):73-79
35. Hesselbrock VM: The genetic epidemiology of alcoholism, in The Genetics of Alcoholism: Alcohol and Alcoholism, vol 1. Edited by Begleiter H, Kissin B. Oxford, Oxford University Press, 1995
36. Kendler KS, Walters EE, Neale MC, Kessler RC, Heath AC, Eaves LJ: The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Arch Gen Psychiatry 1995; 52:374-383
37. Higley JD, Thompson WW; Champoux M, Goldman D, Hasert MF, Kraemer GW, Scanlan JM, Suomi SJ, Linnoila M: Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (Macaca mulatta). Arch Gen Psychiatry 1993; 50:615-623
38. Oxenstierna G, Edman G, Iselius L, Oreland L, Ross SB, Sedvall G: Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals - a genetic study. J Psychiatr Res 1986; 20:19-29
39. Kraemer GW, Ebert MH, Schmidt DT, McKinney WT: A longitudinal study of the effect of different social rearing conditions on cerebrospinal fluid norepinephrine and biogenic amine metabolites in rhesus monkeys. Neuropsychopharmacology 1989; 2:175-189
40. Shannon C, Champoux M, Higley JD, Dodson A, Higley SB, Suomi SJ, Linnoila M: Interindividual differences in neonatal serotonin functioning: stability of interindividual differences and behavioral correlates (abstract). Am J Primatology 1995; 36: 155
41. Johnson EO, van den Bree MBM, Pickins RW: Subtypes of alcohol-dependent men: a typology based on relative genetic and environmental loading. Alcohol Clin Exp Res 1996; 20: 1472-1480